Via the FDA:”FDA lab tests have confirmed that a counterfeit version of Roche’s Altuzan 400mg/16ml (bevacizumab),an injectable cancer medication, found in the U.S. contains no active ingredient. Even if the identified drugs were not counterfeit, Altuzan is not approved by FDA for use in the United States (it is an approved drug in Turkey).”
For more information, read the entire article here: Altuzan (bevacizumab): Counterfeit Product – Contains no Active Ingredient
Know more about Sproxil Anti-Counterfeit Technology
